Overview
The life sciences industry is characterized, in large part, by unending innovation driven by the constant demand for new medical therapies. It is equally characterized by a robust but evolving regulatory framework in which the development of new technologies tends to outpace the laws needed to govern them.
In such a dynamic environment dominated by compliance issues and enforcement concerns, savvy legal advice is essential to an organization’s success.
At Epstein Becker Green, we have a tight-knit team of life sciences attorneys and advisors with strong backgrounds in science, industry, and government. Our clients are often on the leading edge of new technologies, and they trust us to guide them in areas where the regulatory picture remains unclear. We help them understand the law and its practical implications so they can adopt workable approaches to their legal, regulatory, and business issues.
Navigating the Regulatory Landscape
In an industry where stringent compliance obligations accompany every facet of a product’s development and commercialization, few companies can navigate the regulatory landscape without help. Our clients look to us to devise an overall regulatory strategy for their product, and we work with them to decide how that strategy will be implemented. How and by whom will the therapy be used? What research will be needed? What claims will need substantiating? What reimbursement schemes make the most sense? The answers to such questions—and countless similar ones—form the basis of each application for regulatory approval and provide our clients with roadmaps for addressing compliance issues going forward.
Our deep understanding of the applicable regulatory bodies and their enforcement mechanisms is key to every aspect of our client service. We represent clients in front of all such bodies, both in routine matters and in investigative inquiries. Our lawyers advise them on the development of their manufacturing and distribution systems. We arrange contracts defining their relationships with customers, vendors, and payors. We review their pricing options and sign off on advertising and promotional communications. Each of these efforts—and much more—is designed to ensure that all operations are fully optimized from both a business and a regulatory standpoint.
Serving Our Clients
Our team of life sciences attorneys and advisors serves organizations across the length and breadth of the life sciences industry, including:
- Academic centers
- Artificial intelligence companies
- Biotechnology companies
- Clinical laboratories
- Combination product manufacturers
- Digital health (IoT) companies
- Food and Dietary Supplements
- Genetics and Genomics
- Human cellular and tissue products (HCT/P) manufacturers
- In vitro diagnostic innovators
- Investors in the life sciences industry
- Medical device manufacturers
- Pharmaceutical and biologic manufacturers
- Precision medicine laboratories
- Research institutions and investigators
- Research services vendors (including contract research organizations and site management organizations
- Suppliers and distributors
- Telehealth companies
- Trade associations and industry coalitions
We cover a broad scope of products and services that fall within these general categories: research and development, clinical research support, product commercialization, FDA regulatory strategy, compliance and training, litigation, and transactions and capitalization.
Read less
Focus Areas
Services
- Academic and Clinical Research
- ADA and Public Accommodations
- Affirmative Action/OFCCP Compliance
- Appellate
- Business Torts, Competition & Trade Secrets
- Class Actions
- Commercial and Contract Litigation
- Corporate & Transactional
- Corporate and Securities Litigation
- Corporate Compliance Program Development, Implementation, and Effectiveness
- Corporate Financing
- Corporate Governance
- Corporate Reorganization
- Cross-Border Data Transfers
- Cross-Border Transactions
- Cybersecurity Risk Assessment
- Data Asset Management
- Data Breach and Incident Response
- Data Breach/Cybersecurity Investigations & Litigation
- Data Protection
- DEI Compliance and Legal Counseling
- Dietary Supplement Litigation
- Digital Health
- Drug and Medical Device Coding, Coverage, and Payment
- Drug and Medical Device Distribution
- Drug and Medical Device Litigation
- Drug Pricing Policy & Reporting
- Employee Benefits and ERISA
- Employment Compliance Counseling
- Employment Litigation
- Employment Training
- Employment, Labor & Workforce Management
- ERISA – Retirement and Benefit Plan Litigation
- Executive Compensation
- FDA Inspections and Enforcement
- Federal Research Grants: Compliance, Investigations & Enforcement
- Financial Restructuring and Bankruptcy
- Foreign Multinational Counseling and Litigation
- General Counsel Services
- Health Care
- Health Care and Life Sciences Investigations and Enforcement
- Health Care and Life Sciences Investor Services
- Health Policy and Legislation
- Immigration
- Industry Research and Clinical Trials
- Insider Threats
- Intellectual Property
- Intellectual Property Litigation
- Internet of Things (IoT)
- Labor and Employment Due Diligence
- Labor Management Relations
- Life Sciences
- Life Sciences Due Diligence
- Litigation & Business Disputes
- Mergers, Acquisitions & Divestitures
- Occupational Safety and Health (OSHA)
- Pandemic Workforce Issues
- Pay Equity
- Privacy Compliance Strategies
- Privacy, Cybersecurity & Data Asset Management
- Product Marketing and Compliance
- Ransomware
- Real Estate
- Regulatory Strategy, Product Development, and Product Approvals
- Remote and Hybrid Work
- Social Media and the Workplace
- State Privacy Law Compliance
- Tax and Tax-Exempt Counseling
- Trade Secrets & Employee Mobility
- Wage and Hour
- Whistleblowing and Compliance
- White Collar Defense and Internal Investigations
- Workforce Government Relations
- Workforce Restructuring and Other Cost-Saving Mechanisms
- Workplace Investigations
Industries
Representative Experience
Our Team
Media
Events
Upcoming Events
Past Events
Insights
Insights
- BlogsComment Period Closes on California OHCA’s Proposed Emergency Regulations Expanding Private Equity, Hedge Fund, and MSO ...5 minute read
- Blogs
DOJ Revises Justice Manual on Non-Binding Guidance and Qui Tam Dismissals: Practical Considerations
9 minute read - Firm AnnouncementsEpstein Becker Green’s Litigation Team Earns “Powerhouse” Recognition in the BTI Litigation Outlook 2027 Report ...2 minute read
- PublicationsFTC Chair Andrew Ferguson Signals Reduction in Administrative Litigation2 minute read
- PublicationsDistrict of Columbia Bucks National Trend on Paid Leave, Rolls Back Benefits6 minute read
- BlogsAdditional SBA Crackdown on Pandemic-Era Fraud Leads to Program and Loan Suspensions, Possible FCA Enforcement6 minute read
- Media Coverage
Richard Hughes Quoted in Law360 Healthcare Authority on Turmoil at the U.S. Preventive Services Task Force
2 minute read - PublicationsNew York Enacts Personnel File Access Law: Employer Obligations and Deadlines8 minute read
- BlogsNew DOL Guidance Reiterates Key Priorities for MHPAEA Enforcement9 minute read
- BlogsThe Largest Sunshine Act Penalty in History - Pharmaceutical Company Settles False Claims Act, Anti-Kickback Statute and ...4 minute read
- Publications250+ Health Care Entities Targeted by HHS, DOJ Over Gender-Affirming Care for Minors35 minute read
- Firm AnnouncementsEpstein Becker Green Named Finalist for Litigation Department of the Year in New Jersey Legal Awards 20264 minute read
- PublicationsWorkplace AI Regulation in 2026: How Employers Can Navigate the Changing Legal Landscape28 minute read
- BlogsBill Gates Gazes into the AI Crystal Ball: What are the Implications on the Healthcare and Life Sciences Industry ...5 minute read
- Firm AnnouncementsElizabeth McEvoy Named a “Go To Life Sciences/Healthcare Lawyer”3 minute read
- Media CoverageElizabeth McEvoy Featured as a "Go To Life Sciences/Healthcare Lawyer" by Massachusetts Lawyers Weekly2 minute read
- Media Coverage
Richard Hughes Quoted in Law360 Healthcare Authority on Trump Vaccine Order's Limits Under State Law
2 minute read - Blogs250+ Health Care Entities Targeted by HHS, DOJ Over Gender-Affirming Care for Minors5 minute read
- BlogsExclusion Authority (It’s Not Just the HHS-OIG Anymore …)7 minute read
- BlogsThe Sixth Circuit Revives the Medicare Waiver of Liability for Overpayments and Appeals5 minute read
- BlogsThe Department of Justice's National Fraud Enforcement Division: A New Era of Coordinated Fraud Prosecution and What It ...8 minute read
- BlogsFederal Court Holds Idaho’s Near-Total Abortion Ban Unconstitutional for Lack of Health Exception11 minute read
- BlogsHRSA Announces Revised 340B Rebate Model Pilot Program for 202719 minute read
- Firm Announcements
Epstein Becker Green Attorneys Honored for Excellence in the Legal Profession by Best Lawyers 2027
11 minute read - PublicationsModernizing Compliance: DOL Proposes Safe Harbor for Electronic Group Health Plan Disclosures Under ERISA14 minute read
- BlogsWhen AI Becomes Part of Medicine: Why CMS’s AI Questions Matter Now7 minute read
- Firm AnnouncementsDavid Shillcutt Named 2026 BTI Client Service All-Star4 minute read
- PublicationsDOJ Announces Resumption of “Targeted HSR Merger Review Process”2 minute read
- BlogsWatch: Change Is Coming from the EEOC—but When? - Employment Law This Week6 minute read
- Media Coverage
Richard Hughes Quoted in Oncology Nurse Advisor on Misinformation's Threat to mRNA Cancer Vaccine Development
2 minute read - PublicationsFTC Secures Largest Penalty to Date for HSR Violation2 minute read
- Media Coverage
Alaap B. Shah Featured in PYMNTS on Building Defensible AI Governance in Health Care
3 minute read - BlogsWatch: New York Employers Face New Restrictions on Severance, Tuition Repayment, and Sick Time - Employment Law This Week5 minute read
- PublicationsVirginia Employers: Get Ready for Expanded Paid Sick Leave8 minute read
- BlogsExecutive Order 14321 at One Year: Civil Commitment Policy Shifts and Provider Impact9 minute read
- Media Coverage
James Frank Quoted in Law360 Employment Authority on NLRB's Health Care Bargaining Unit Rule
2 minute read - BlogsWatch: FDA’s 2026 Enforcement Priorities: What In-House Counsel Must Know – Thought Leaders in Health Law5 minute read
- PublicationsAI Legislation: 2026 Legislative Wrap-Up10 minute read
- PublicationsState AI Law Tracker7 minute read
- Firm AnnouncementsEpstein Becker Green Launches Interactive Map of Enacted State AI Laws and Bills for Health Care, Life Sciences, and ...4 minute read
- Publications
“The House Is White”: Justice Gorsuch’s Concurrence in Trump v. Slaughter and the Coming Reckoning for Delegated ...
22 minute read - PublicationsCMS Seeks Broad Stakeholder Input on CLIA Regulations, Signaling Potential Modernization of Current Lab Regulatory Scheme ...12 minute read
- BlogsThe Future of 340B: New Bills Offer Competing Solutions to Modernize the 340B Drug Discount Program13 minute read
- BlogsThe Death of Disparate Impact? What Recent DOJ Guidance Signals to Employers8 minute read
- BlogsWatch: Beyond the EEOC - the Widening Divide in Disparate Impact Enforcement - Employment Law This Week5 minute read
- Media Coverage
Sarah Hall and Allison Ness Quoted in Law360 Healthcare Authority on Federal Pressure on State Medicaid Fraud Units ...
2 minute read - Media Coverage
Richard Hughes Quoted in STAT News on RFK Jr.'s Plan to Create a COVID-19 Vaccine Injury Compensation Table
2 minute read - BlogsWatch: The NLRB Is No Longer Independent—What Employers Need to Know - Employment Law This Week6 minute read
- PublicationsLooming Class Action Litigation Risk and DOJ’s Bulk Sensitive Data Transfer Rule: Navigating an Unexpected Compliance ...13 minute read
- Blogs"Enough Is Enough": HHS-OIG Freezes Funds for New York Medicaid Fraud Control Unit, Effective July 19 minute read

